Crescent Capital BDC: Additional Downside Risks Remain (Rating Downgrade)

CCAP downgraded to sell as NAV falls, non-accruals rise, and dividend coverage weakens. Click here to read my most recent analysis of CCAP stock.

You are being redirected to the original discussion. Please continue if you want to read the full post.

Continue to original article

You will be redirected in 3 seconds.